Microsoft perceived to be one of the best qualified to implement new technologies that will advance genomics research

Congrat's on being named one of the 5 companies capable of making an impact in Bioinformatics. According to a recent market survey, MSFT was among the best. Here're the links:

https://gene2drug.com/about/news.asp?newsId=162

https://gene2drug.com/reports.89.html